Moreover, the identification of novel DUOXA2 missense mutation in a transient CH patient with a large deletion comprising DUOX2, DUOXA2, and DUOXA1 (17) suggests that DUOXA1 mutation may lead to CH as DUOXA2 mutation does. This evidence concerns the gene DUOX2 and cyclic hematopoiesis.